UroMems, founded in 2011, focuses on the design, development and marketing of active implantable medical devices for the treatment of severe stress urinary incontinence. At UroMems, world-class researchers, engineers, surgeons and entrepreneurs sharing common values have been working together for more than ten years to address a considerable health problem with significant social and economic implications. The company's headquarters are located on the Minatec campus in Grenoble, a European micro and nanotechnology innovation hub. UroMems has been awarded by multiple distinctions and prizes including innovation grants from Bpifrance and the Worldwide Innovation Challenge (CMI) prize, phase I & II.